Papulopustular rosacea (inflammatory rosacea)

Understanding Rosacea: Symptoms, Causes, Diagnosis, and Treatment

Introduction

Rosacea is a chronic skin condition primarily affecting the face, characterized by persistent redness, visible blood vessels, and often, acne-like bumps. This condition typically manifests in middle-aged adults but can affect individuals as young as 20. Despite its prevalence and impact, the exact cause of rosacea remains unclear, though several factors are believed to contribute to its development.

Signs and Symptoms

Rosacea often begins with redness in the central part of the face, particularly around the nose, cheeks, forehead, and chin. This initial flushing can be triggered by various factors including stress, hot drinks, spicy foods, and extreme weather conditions. Over time, rosacea can progress to more severe symptoms:

• Erythematotelangiectatic Rosacea: Characterized by persistent redness and flushing, accompanied by visible small blood vessels (telangiectasias). The skin may feel sensitive, dry, or flaky.
• Papulopustular Rosacea: Features red bumps (papules) and pus-filled pustules that can resemble acne. This subtype may also involve some permanent redness.
• Phymatous Rosacea: Known for its thickening of the skin, especially on the nose (rhinophyma). It can also affect other facial areas like the chin (gnathophyma) and ears (otophyma).
• Ocular Rosacea: Affects the eyes and eyelids, causing redness, irritation, and sensitivity to light. In severe cases, it can lead to keratitis, which may result in vision problems.

Common triggers for rosacea flares include ultraviolet light, heat, cold, certain foods, and beverages. Medications and topical irritants can also exacerbate the condition.

Causes

The precise cause of rosacea is not fully understood. However, several factors are believed to contribute to its onset:

• Genetics: A family history of rosacea may increase susceptibility.
• Environmental Triggers: Exposure to temperature extremes, sunlight, and certain foods and drinks can provoke symptoms.
• Medications and Irritants: Topical steroids and certain acne treatments may induce or worsen rosacea.
• Cathelicidins: These antimicrobial peptides, elevated in rosacea patients, may play a role in inflammation.
• Demodex Mites: Increased numbers of Demodex mites, which are normally found on the skin, may be linked to rosacea.
• Intestinal Bacteria: Small intestinal bacterial overgrowth (SIBO) has been associated with rosacea, though the connection is still under investigation.

Diagnosis

Diagnosing rosacea typically involves a visual inspection by a healthcare professional based on characteristic symptoms. There is no definitive test for rosacea, so diagnosis often relies on identifying the pattern of redness, bumps, and other symptoms. The condition can be confused with acne, seborrheic dermatitis, or other skin issues, but a detailed medical history and symptom evaluation usually clarify the diagnosis.

Classification

Rosacea is classified into four main subtypes:

1. Erythematotelangiectatic Rosacea: Persistent facial redness and flushing with visible blood vessels.
2. Papulopustular Rosacea: Red bumps and pustules, often mistaken for acne.
3. Phymatous Rosacea: Thickened skin, especially around the nose and chin.
4. Ocular Rosacea: Eye irritation and redness, with symptoms like dryness and sensitivity.

Additional variants include pyoderma faciale and rosacea conglobata, which are more severe forms of the condition.

Treatment

While there is no cure for rosacea, various treatments can manage symptoms effectively:

• Behavioral Changes: Avoiding known triggers, using sunscreen, and opting for non-irritating skin products can help control symptoms.
• Medications:
  • Topical Treatments: Metronidazole, ivermectin, and azelaic acid can reduce inflammation and redness.
  • Oral Medications: Doxycycline and tetracycline, and in severe cases, isotretinoin, are used to manage more intense symptoms.
  • Topical Minocycline: Approved for its targeted approach in reducing inflammatory lesions.
• Laser Therapy: Though evidence is limited, laser treatments can help with visible blood vessels and redness.
• Other Options: Alpha-hydroxy acid peels and cyclosporine eye drops for ocular symptoms.

Outcomes and Prognosis

Rosacea can significantly impact self-esteem and social interactions due to its visible symptoms. While treatment can reduce symptoms and flare-ups, the condition often requires ongoing management. Some individuals may experience long-term relief, while others may need continuous treatment to control the condition.

Epidemiology

Rosacea affects approximately 5% of the global population, with a higher prevalence in individuals with fair skin and those of Celtic heritage. It commonly begins in adults aged 30 to 50 and is equally likely to affect men and women.

Conclusion

Rosacea is a complex condition with varied symptoms and triggers, requiring a tailored approach to treatment. While the exact cause remains elusive, managing triggers and utilizing appropriate treatments can significantly improve quality of life for those affected.

References

1. Sand M, Sand D, Thrandorf C, et al. “Cutaneous lesions of the nose”. Head & Face Medicine. 6: 7. doi:10.1186/1746-160X-6-7.
2. Tüzün Y, Wolf R, Kutlubay Z, et al. “Rosacea and rhinophyma”. Clinics in Dermatology. 32 (1): 35–46. doi:10.1016/j.clindermatol.2013.05.024.
3. “Questions and Answers about Rosacea”. National Institute of Arthritis and Musculoskeletal and Skin Diseases. April 2016.
4. van Zuuren EJ, Fedorowicz Z. “Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments”. The British Journal of Dermatology. 173 (3): 651–62. doi:10.1111/bjd.13956.
5. Rainer BM, Kang S, Chien AL. “Rosacea: Epidemiology, pathogenesis, and treatment”. Dermatoendocrinol. 9 (1): e1361574. doi:10.1080/19381980.2017.1361574.
6. Zouboulis CC, Katsambas AD, Kligman AM. Pathogenesis and Treatment of Acne and Rosacea. Springer.
7. Schachner LA, Hansen RC. Pediatric Dermatology E-Book. Elsevier Health Sciences.
8. Wilkin J, Dahl M, Detmar M, et al. “Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea”. J Am Acad Dermatol. 50 (6): 907–12. doi:10.1016/j.jaad.2004.01.048.
9. Buddenkotte J, Steinhoff M. “Recent advances in understanding and managing rosacea”. F1000Research. 7: 1885. doi:10.12688/f1000research.16537.1.
10. James, William; Berger, Timothy; Elston, Dirk. Andrews’ Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders.
11. Del Rosso JQ. “Management of cutaneous rosacea: emphasis on new medical therapies”. Expert Opin Pharmacother. 15 (14): 2029–38. doi:10.1517/14656566.2014.945423.